St Jude Medical (STJ) Reports Mixed Q3 Results; Guides Q4, Raises FY10 Outlook

October 20, 2010 7:38 AM EDT
Get Alerts STJ Hot Sheet
Trade STJ Now!
Join SI Premium – FREE
St Jude Medical (NYSE: STJ) Reports Q3 EPS of $0.72, ex-items, 4 cents better than the analyst estimate of $0.68. Revenue for the quarter was $1.24 billion, which compares to the estimate of $1.25 billion.

Sees Q4 EPS of 72-74c, vs. the consensus of 70c

Raises its FY10 EPS guidance from $2.86-$2.91 to $2.98-$3, which compares to the Street estimate of $2.91.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance, Hot List

Add Your Comment